Decisions about treatment with a cholinesterase inhibitor should be individualized and based on the informed consent/assent of the patient. At follow-up visits the patient has to be assessed for ...

Cholinesterase inhibitors prevent the breakdown of a type of neurotransmitter called acetylcholine. Doctors may prescribe this medication for certain neurodegenerative diseases, such as Alzheimer ...

Who Should be Started on a Cholinesterase Inhibitor? A ChEI is an option for most people with mild to moderate AD (the commonly seen behavioural signs of this phase of AD are shown in Table 1).

Possible treatments include patient-initiated coping strategies, a reduction of antiparkinson medications, atypical neuroleptics and, potentially, cholinesterase inhibitors. Evidence-based studies ...

This means that their nerve cells lose the ability to talk to each other properly. Cholinesterase inhibitors, like donepezil, rivastigmine and galantamine, can boost acetylcholine levels. This helps ...

Alzheimer’s disease (AD) is a degenerative neurological condition that affects millions of people around the world.

Specifically, the results were "highly suggestive" of something called cholinesterase inhibitor intoxication. Cholinesterase is an important enzyme in the human nervous system, and blocking it ...

Physicians often resort to off-label use of medications approved for AD, such as cholinesterase inhibitors (ChEIs) and memantine. These drugs target symptoms but do not halt disease progression.

Reversible acetylcholinesterase inhibitor (benzazepine deriv). Galantamine, a tertiary alkaloid, is a competitive and reversible inhibitor of acetylcholinesterase. While the precise mechanism of ...